Conference Details - Overview
Bard Biopsy Systems: The NEW FINESSE™ ULTRA Breast Biopsy System Hands-On Workshop (Room: Splash 9)
*Part of 27th Annual Miami Breast Cancer Conference™
Miami, FL
March 5, 2010
Conference Overview
Bard Biopsy Systems, A Business Unit of Bard Peripheral Vascular, Inc. Bard is the world leader in biopsy innovations. Bard’s newest innovation, the Finesse™ Ultra Breast Biopsy System, is the only self-contained, vacuum-assisted, ultrasound-guided breast biopsy system with SIMS Technology—the ability to acquire multiple samples with a single probe insertion. With sampling cycle time just 10 seconds, the Finesse Ultra Breast Biopsy System acquires large, high-quality, contiguous tissue samples rapidly from a single insertion. Its ultrasharp cutting tip and optional piercing mode penetrates dense breast tissue and lesions accurately without displacing the lesion. The detachable integrated coaxial cannula can remain in the breast to maintain a track to the biopsy site to accurately place a breast tissue marker. The Finesse Ultra Breast Biopsy System provides compassionate control of the patient experience, confident control of sample quality, and efficient control of the biopsy procedure.
Hands-on Workshops are intended for participants of the 27th Miami Breast Cancer Conference. You must be registered for the main conference in order to attend a Hands-on Workshop.